As Co-Founder and Chief Commercial Officer at Clerkenwell Health, I am deeply committed to accelerating psychiatric and CNS research. At Clerkenwell Health, we’re addressing a critical gap in the UK clinical trial landscape. Innovative psychiatric and CNS research is experiencing rapid growth as is the demand for timely, expert-led trials.With over 10 years of experience in psychoactive drug policy and research, my career began at the Beckley Foundation, followed by a pivotal role in the UK’s medical cannabis legalization campaign at Volteface. I later founded Hanway Associates, Europe’s then leading cannabis industry advisory firm, and co-created the industry conference Cannabis Europa. My strengths lie in regulatory strategy, market development, and building strategic partnerships.I’m always open to collaboration on neuropsychiatric research, new treatments, or projects aligned with shaping the future of mental health care.